Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Navamedic Director's Dealing 2019

Dec 23, 2019

3668_dirs_2019-12-23_0d8238e3-4511-40e9-819a-79b8a38da8e7.html

Director's Dealing

Open in viewer

Opens in your device viewer

Disclosure of trade

Disclosure of trade

With reference to disclosure requirements set out in section 4-2 of the Norwegian Securities Trading Act, Lars Hjarrand, a primary insider as Chief Financial Officer in Navamedic ASA, has on December 20th, 2019 acquired 132.882 shares in Navamedic ASA at an average price of 16,5564 NOK. After this transaction Lars Hjarrand owns 132.882 shares in the company.